UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023456
Receipt number R000026030
Scientific Title Randomized control stuy for the effect of dentifrice including mastic and fulvic acid on periodontal symptoms
Date of disclosure of the study information 2016/08/03
Last modified on 2022/08/11 14:31:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized control stuy for the effect of dentifrice including mastic and fulvic acid on periodontal symptoms

Acronym

Effect of dentifrice including mastic and fulvic acid

Scientific Title

Randomized control stuy for the effect of dentifrice including mastic and fulvic acid on periodontal symptoms

Scientific Title:Acronym

Effect of dentifrice including mastic and fulvic acid

Region

Japan


Condition

Condition

periodontal disease

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to evaluate the effect of dentifrice including mastic and fulvic acid on periodontal symptoms using randomized controlled study

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

clinical parameters such as swelling and redness of gingiva, bleeding, discharge of pus, periodontal pocket depth, moving of teeth, halitosis and whiteness of teeth were evaluated at start of dentifrice usage,4,8 and 12 weeks later

Key secondary outcomes

microbiological test was performed at dentifrice usage, 4, 8 and 12 weeks later


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Dentifrice A:Mastic essential oil(0.01g)
Instructed to use dentifrice(1g),1cm for 7 min twice a day(morning, evening) during 12 weeks.

Interventions/Control_2

Dentifrice B: Mastic essential oil(0.01g)+ Fulvic acid(10g)
Instructed to use dentifrice(1g),1cm for 7 min twice a day(morning, evening) during 12 weeks.

Interventions/Control_3

Dentifrice (Placebo): without Mastic and Fulvic acid and same as others
Instructed to use dentifrice(1g),1cm for 7 min twice a day(morning, evening) during 12 weeks.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Chronic periodontitis patients who did not received scaling at observed site within 6 months and are at first visit or plaque control stage.

Key exclusion criteria

A) Systemic diseases which affect to periodontal tissue
B) Severe periodontal diseases
C) Anteriol teeth lost or applied orthodontic apparatus
D) Pregnant or lactating woman
E) Antibiotics experience within 3 months

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hisashi
Middle name
Last name Watanabe

Organization

Tokyo Medical and Dental University

Division name

Graduate School of Medical and Dental Sciences, Department of Periodontology

Zip code

113-8510

Address

1-5-45, Yushima Bunkyo-ku Tokyo

TEL

03-5803-5487

Email

watanabe.peri@tmd.ac.jp


Public contact

Name of contact person

1st name Akiho
Middle name
Last name Sato

Organization

Tokyo Medical and Dental University

Division name

the general affairs section

Zip code

113-8510

Address

1-5-45, Yushima Bunkyo-ku Tokyo

TEL

03-5803-5404

Homepage URL


Email

rec.adm@tmd.ac.jp


Sponsor or person

Institute

the Ministry of Welfare and Labor

Institute

Department

Personal name



Funding Source

Organization

Zeria Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB at Tokyo Medical and Dental University, Dental School

Address

1-5-45, Yushima Bunkyo-ku Tokyo

Tel

03-5803-5404

Email

rec.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 03 Day

Date of IRB

2016 Year 08 Month 01 Day

Anticipated trial start date

2016 Year 08 Month 03 Day

Last follow-up date

2019 Year 08 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 08 Month 03 Day

Last modified on

2022 Year 08 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026030


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name